|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Excess and obsolescence inventory reserve | |||||
| Gain on sale of assets | |||||
| Inventory write-off | |||||
| Loss (gain) on disposal of assets | |||||
| Deferred income taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables | |||||
| Inventories | |||||
| Trade accounts payable and accrued expenses | |||||
| Contract liability with customers | |||||
| Employee compensation and benefits | |||||
| Product liability | |||||
| Prepaid expenses, other assets and other liabilities | |||||
| Income taxes receivable/payable | |||||
| Cash provided by operating activities | |||||
| Investing Activities | |||||
| Property, plant and equipment additions | |||||
| Purchase of Anderson Manufacturing assets | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturity of short-term investments | |||||
| Net proceeds from sale of assets | |||||
| Cash (used for) provided by investing activities | |||||
| Financing Activities | |||||
| Dividends paid | |||||
| Repurchase of common stock | |||||
| Payment of employee withholding tax related to share-based compensation | |||||
| Cash used for financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year |
Loading...
